AU728909B2 - Immunological method - Google Patents
Immunological method Download PDFInfo
- Publication number
- AU728909B2 AU728909B2 AU76631/98A AU7663198A AU728909B2 AU 728909 B2 AU728909 B2 AU 728909B2 AU 76631/98 A AU76631/98 A AU 76631/98A AU 7663198 A AU7663198 A AU 7663198A AU 728909 B2 AU728909 B2 AU 728909B2
- Authority
- AU
- Australia
- Prior art keywords
- specific
- cell
- cells
- antigen
- subset
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9710820 | 1997-05-27 | ||
GBGB9710820.3A GB9710820D0 (en) | 1997-05-27 | 1997-05-27 | Immunological method |
PCT/GB1998/001382 WO1998054223A2 (en) | 1997-05-27 | 1998-05-27 | Immunological method |
Publications (2)
Publication Number | Publication Date |
---|---|
AU7663198A AU7663198A (en) | 1998-12-30 |
AU728909B2 true AU728909B2 (en) | 2001-01-18 |
Family
ID=10813057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU76631/98A Ceased AU728909B2 (en) | 1997-05-27 | 1998-05-27 | Immunological method |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1017724A2 (ja) |
JP (1) | JP2001517958A (ja) |
AU (1) | AU728909B2 (ja) |
CA (1) | CA2291004A1 (ja) |
GB (1) | GB9710820D0 (ja) |
WO (1) | WO1998054223A2 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1243327A1 (de) * | 2001-03-19 | 2002-09-25 | BioChip Technologies GmbH | Oberfläche mit einem Muster aus Zellen und Verfahren zu deren Herstellung |
GB0128153D0 (en) * | 2001-11-23 | 2002-01-16 | Bayer Ag | Profiling of the immune gene repertoire |
ES2478446T3 (es) | 2003-06-27 | 2014-07-22 | International Institute Of Cancer Immunology, Inc. | Método de selección de pacientes candidatos para la vacuna contra WT1 |
EP3173480A3 (en) | 2007-03-05 | 2017-08-16 | International Institute of Cancer Immunology, Inc. | Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them |
US9803246B2 (en) | 2011-06-28 | 2017-10-31 | International Institute Of Cancer Immunology, Inc. | Receptor gene for peptide cancer antigen-specific T cell |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2671356B1 (fr) * | 1991-01-09 | 1993-04-30 | Inst Nat Sante Rech Med | Procede de description des repertoires d'anticorps (ab) et des recepteurs des cellules t (tcr) du systeme immunitaire d'un individu. |
JPH07504399A (ja) * | 1991-08-28 | 1995-05-18 | ザ・ウィスター・インスティチュート | T細胞リセプターに基づいた慢性間接リウマチの治療法 |
WO1994014067A1 (en) * | 1992-12-14 | 1994-06-23 | T Cell Sciences, Inc. | Diagnosis and therapy of sarcoidosis |
AU3878697A (en) * | 1996-06-20 | 1998-02-02 | Cornell Research Foundation Inc. | Identification of abnormalities in the expression of t and cell antigen receptors as indicators of disease diagnosis, prognosis and therapeutic predictors |
-
1997
- 1997-05-27 GB GBGB9710820.3A patent/GB9710820D0/en active Pending
-
1998
- 1998-05-27 EP EP98924427A patent/EP1017724A2/en not_active Withdrawn
- 1998-05-27 CA CA002291004A patent/CA2291004A1/en not_active Abandoned
- 1998-05-27 JP JP50035099A patent/JP2001517958A/ja active Pending
- 1998-05-27 AU AU76631/98A patent/AU728909B2/en not_active Ceased
- 1998-05-27 WO PCT/GB1998/001382 patent/WO1998054223A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2291004A1 (en) | 1998-12-03 |
EP1017724A2 (en) | 2000-07-12 |
GB9710820D0 (en) | 1997-07-23 |
WO1998054223A2 (en) | 1998-12-03 |
WO1998054223A3 (en) | 1999-03-04 |
AU7663198A (en) | 1998-12-30 |
JP2001517958A (ja) | 2001-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0463101B2 (en) | Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations | |
Weyand | New insights into the pathogenesis of rheumatoid arthritis | |
US5298396A (en) | Method for identifying T cells disease involved in autoimmune disease | |
US20070238099A1 (en) | Antigen Receptor Variable Region Typing | |
Norris et al. | Oligoclonal expansion of intraepidermal T cells in psoriasis skin lesions | |
KR20060033899A (ko) | T 세포 수용체 서열, 및 류마티스 관절염을 검출 및치료하는 방법 | |
Müschen et al. | Involvement of soluble CD95 in Churg-Strauss syndrome | |
EP0722738A2 (en) | Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations | |
US7972848B2 (en) | Isolation and identification of cross-reactive T cells | |
WO1991009623A1 (en) | Diagnosis and treatment of diseases | |
US6464978B1 (en) | Vaccination and methods against multiple sclerosis resulting from pathogenic responses by specific T cell populations | |
AU3418893A (en) | Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations | |
AU728909B2 (en) | Immunological method | |
WO2002089832A2 (en) | Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio. | |
US5837246A (en) | Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations | |
WO1993004695A1 (en) | T cell receptor-based therapy for rheumatoid arthritis | |
Moesta et al. | T cell receptor β chain gene usage in endemic pemphigus foliaceus (Fogo Selvagem) | |
AU648753C (en) | Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations | |
Walters | T cell repertoires in animal and huma glomerulonephritis | |
WO2004084822A2 (en) | Methods for inducing immune tolerance | |
Klatzmann et al. | Severe Perturbations of the Blood T Cell | |
AU6440999A (en) | Composition for preventing or treating a T-cell mediated pathology |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |